Fisher & Paykel Healthcare Limited EBIT

As of the most recent data (March 2026), FPH.NZ shows a EBIT of $1.4B. That compares with $690M in the prior-year period — up 102.9% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FPH.NZ's EBIT is now $1.4B (was $690M) — a 102.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fisher & Paykel Healthcare Limited is outperforming or lagging.

The its sector sector average EBIT is about $2.6T. Fisher & Paykel Healthcare Limited is at $1.4B, which is lower that average. That is roughly 99.9% below the sector mean. Use the comparison chart on this page to see how FPH.NZ stacks up against individual peers as well.

Tracking FPH.NZ's ebit over time shows whether Fisher & Paykel Healthcare Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4B That compares with $690M in the prior-year period — up 102.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Fisher & Paykel Healthcare Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $1.4B) with ownership activity and broader fundamentals.